Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Armata Pharmaceuticals, Inc. | Financial_Report.xls |
| EX-3.5 - EXHIBIT 3.5 - Armata Pharmaceuticals, Inc. | v407144_ex3-5.htm |
| EX-14.1 - EXHIBIT 14.1 - Armata Pharmaceuticals, Inc. | v407144_ex14-1.htm |
| EX-31.1 - EXHIBIT 31.1 - Armata Pharmaceuticals, Inc. | v407144_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Armata Pharmaceuticals, Inc. | v407144_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - Armata Pharmaceuticals, Inc. | v407144_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Armata Pharmaceuticals, Inc. | v407144_ex32-1.htm |
| EX-23.2 - EXHIBIT 23.2 - Armata Pharmaceuticals, Inc. | v407144_ex23-2.htm |
| 10-K - FORM 10-K - Armata Pharmaceuticals, Inc. | v407144_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-1 No. 333-193458) of AmpliPhi Biosciences Corporation and in the related Prospectus of our report dated April 15, 2015, with respect to the consolidated financial statements of AmpliPhi Biosciences Corporation included in this Annual Report (Form 10-K) for the year ended December 31, 2014.
/s/ Ernst & Young LLP
Richmond, Virginia
April 15, 2015